Company: SWKH
Filing Date: 2025-04-29
Form Type: ANNLRPT
Source: 0001628280-25-020720
Chunk: 57

Company: SWK Holdings Corp
Filing Date: 2025-04-29
Form: ANNLRPT
Chunk 57
---
 |
| Commitments and contingencies (Note 9)                                                                                                                                             |     |                         |            |     |   |            |
| Stockholders' equity:                                                                                                                                                              |     |                         |            |     |   |            |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding                                                                                   |     |                         |          — |     |   |          — |
| Common stock, $0.001 par value; 250,000,000 shares authorized; 12,213,599 and 12,497,770 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively |     |                         |         12 |     |   |         12 |
| Additional paid-in capital                                                                                                                                                         |     |                         |  4,419,991 |     |   |  4,425,104 |
| Accumulated deficit                                                                                                                                                                |     |                         | -4,131,313 |     |   | -4,144,801 |
| Total stockholders' equity                                                                                                                                                         |     |                         |    288,690 |     |   |    280,315 |
| Total liabilities and stockholders' equity                                                                                                                                         |     | $                       |    332,235 |     | $ |    334,254 |

<div align='center'>See accompanying notes to the consolidated financial statements.

34

S</div>

### WK HOLDINGS CORPORATION

### CONSOLIDATED STATEMENTS OF INCOME
<div align='center'>(In thousands, except per share data)</div>

|                                                                      |     | Year Ended December 31, |   2024 |     |   |   2023 |
|:---------------------------------------------------------------------|:----|:------------------------|-------:|:----|:--|-------:|
| Revenues:                                                            |     |                         |        |     |   |        |
| Finance receivable interest income, including fees                   |     | $                       | 40,787 |     | $ | 36,346 |
| Pharmaceutical development                                           |     |                         |  3,616 |     |   |  1,202 |
| Other                                                                |     |                         |    584 |     |   |    212 |
| Total revenues                                                       |     |                         | 44,987 |     |   | 37,760 |
| Costs and expenses:                                                  |     |